Our Story.

MVT in Silico was founded on a simple but powerful belief that rigorous computational science can transform how we understand, prevent, and treat disease. At a time when biomedical research faces rising costs, increasing complexity, and urgent unmet clinical needs, we saw an opportunity to apply deep mathematical modeling, data science, and systems biology to make drug development smarter, faster, and more reliable.

What began as a small group of academic interdisciplinary scientists consisting of mathematicians (the founder) and biologists (Prof. Donald G. Welsh), and clinicians evolved into a focused mission to build transparent, reproducible in silico frameworks that bridge theory and therapeutic impact. From early exploratory modeling projects to structured, validated computational pipelines, our growth has been driven by scientific discipline and an uncompromising commitment to quality. A natural way forward was to pursue the application of Pharmacometrics in addressing the pharma industry's pain points.

Along the way, we recognized that science needs to be both robust and transparent. See our (Science) page. Our story is shaped by the belief that models must be interpretable, verifiable, and grounded in biological reality to truly support decision-making in research and clinical development.